Navigation Links
NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces
Date:3/31/2009

GAITHERSBURG, Md.Researchers at the Commerce Department's National Institute of Standards and Technology (NIST) and Cornell University have capitalized on a process for manufacturing integrated circuits at the nanometer (billionth of a meter) level and used it to develop a method for engineering the first-ever nanoscale fluidic (nanofluidic) device with complex three-dimensional surfaces.

As described in a paper published online today in the journal Nanotechnology,* the Lilliputian chamber is a prototype for future tools with custom-designed surfaces to manipulate and measure different types of nanoparticles in solution.

Among the potential applications for this technology: the processing of nanomaterials for manufacturing; the separation and measuring of complex nanoparticle mixtures for drug delivery, gene therapy and nanoparticle toxicology; and the isolation and confinement of individual DNA strands for scientific study as they are forced to unwind and elongate (DNA typically coils into a ball-like shape in solution) within the shallowest passages of the device.

Nanofluidic devices are usually fabricated by etching tiny channels into a glass or silicon wafer with the same lithographic procedures used to manufacture circuit patterns on computer chips. These flat rectangular channels are then topped with a glass cover that is bonded in place. Because of the limitations inherent to conventional nanofabrication processes, almost all nanofluidic devices to date have had simple geometries with only a few depths. This limits their ability to separate mixtures of nanoparticles with different sizes or study the nanoscale behavior of biomolecules (such as DNA) in detail.

To solve the problem, NIST's Samuel Stavis and Michael Gaitan teamed with Cornell's Elizabeth Strychalski to develop a lithographic process to fabricate nanofluidic devices with complex 3-D surfaces. As a demonstration of their method, the researchers con
'/>"/>

Contact: Michael E. Newman
michael.newman@nist.gov
301-975-3025
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

0

GOOD

Page: 1 2 3 4

Related biology news :

1. New approach builds better proteins inside a computer
2. GM, Coskata partnership builds on Oklahoma State University biofuels research
3. Laminin builds the neuromuscular synapse
4. The best both of worlds -- how to have sex and survive
5. Quantum weirdness, parallel worlds, dinosaur poop, and the ultimate fate of the universe...
6. Which came first, the moth or the cactus?
7. First all-African GM crop is resistant to maize streak virus
8. Scientists retrace evolution with first atomic structure of an ancient protein
9. CU-Boulder team discovers first ancient manioc fields in Americas
10. First finding of a metabolite in 1 sex only
11. First orchid fossil puts showy blooms at some 80 million years old
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces
NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces
(Date:12/11/2009)... release is available in French . ... discovered a novel molecular mechanism that prevents cancer. In ... Molecular Cell , scientists from the Universit de Montral ... that the SOCS1 molecule prevents the cancer-causing activity of ... diseases such as Crohns, in smokers and people exposed ...
(Date:12/11/2009)... 4th edition of Springer,s classic reference and textbook Vogel ... A. McKusick Leadership Award. The prize, which recognizes Professor ... was presented to him at the 59th Annual Meeting ... October 2009 in Honolulu, Hawaii. , Motulsky is Professor ... of Washington in Seattle. One of the founding giants ...
(Date:12/11/2009)... traditionally been limited by the seasons, particularly ... be short. Thanks to researchers and fruit ... that offer growers the ability to produce ... for both producers and consumers. Fresh examples ... "primocane-fruiting", which bear fruit on current-season canes, ...
Breaking Biology News(10 mins):Scientists identify natural anti-cancer defenses 2New management methods extend blackberry season 2Imagenetix 28IAGX 29 Obtains Apology 54489 1Martek Signs Sole Source ARA Supply Agreement with Puleva Food S L 13557 1Martek Signs Sole Source ARA Supply Agreement with Puleva Food S L 13557 2Martek Signs Sole Source ARA Supply Agreement with Puleva Food S L 13557 3ClearWay Minnesota 28SM 29 Adds New Director of Research 54486 1
... geoscientists will gather 12-13 March for the 58th annual ... of America. The meeting takes place at the Hilton ... Geoscientists from the University of South Florida (USF) Department ... USF Geology Alumni Society. , Journalists are invited to ...
... of proteins, detected in incredibly tiny amounts, may one ... the pancreas and a potentially deadly one, say researchers ... researchers believe that these protein biomarkers, if confirmed in ... or precancerous pancreatic lesions, which would allow for earlier, ...
... Commonwealth University Life Sciences researchers have discovered a new ... blood cells, which could lead to the development of ... Malaria is transmitted to humans through bites from mosquitoes. ... between 350 million and 500 million cases of malaria ...
Other Biology News:Tiny samples could yield big predictive markers for pancreatic cancer 2Tiny samples could yield big predictive markers for pancreatic cancer 3Researchers identify new way the malaria parasite and red blood cells interact 2
(Date:12/10/2009)... ON, Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... life sciences product development company that identifies and ... at various stages of development, today provided an ... in the merger of Cytopia Ltd. into YM, ... 2009. The board of directors of Cytopia has ...
(Date:12/10/2009)... Biologic,Products, Inc. (Nasdaq: CBPO ) ("China Biologic," ... companies in China, today announced,that the Company,s senior ... the,NASDAQ MarketSite in New York City at 9:30 ... China Biologic,s common stock began ... 2009, under the ticker symbol "CBPO." , ...
(Date:12/10/2009)... -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin Board: LTUS) ... and,producer of prescription drugs and licensed national ... of China ("PRC"), today reported that,effective December ... entity of Lotus,appointed Mr. Jinzhong HAN to ... division ("OTC Division"). , ...
(Date:12/10/2009)... today that it has entered into a multi-year, sole-source supply ... for the use of Martek’s products in Fonterra’s infant formulas ... , ... Columbia, MD (Vocus) December ... announced today that it has entered into a multi-year, sole-source ...
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3
... of $0.90 to $1.10 for 2009 and $1.50 to $1.70 for ... today announced its financial results for the three and twelve months ... $0.90 to $1.10 for 2009 and $1.50 to $1.70 for 2010. ... Adjusted diluted EPS of $0.26 and ...
... Human Genome Sciences, Inc. (Nasdaq: HGSI ) ... to discuss its financial results for the year ended ... be disclosed on Thursday, February 26, 2009, after the ... call will be hosted by senior management and will ...
... DUBLIN, Ireland, February 19, Shire plc (LSE: SHP, NASDAQ: SHPGY ) the global,specialty biopharmaceutical company announces ... portfolio. , Financial Highlights, ... Full Year 2008 (1) ... $2.75bn + 27% ...
Other Biology Technology:Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 2Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 3Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 4Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 5Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 6Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 7Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 8Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 9Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 10Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 11Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 12Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 13Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 14Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 15Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 16Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008 17Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2008 Financial Results 2Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 2Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 3Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 4Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 5Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 6Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 7Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 8Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 9Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 10Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 11Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 12Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 13Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 14Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 15Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 16Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 17Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 18Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 19
These Costar 96-well, flat-bottom polystyrene EIA plates are used for EIAs, ELISAs, and other protein binding assays. Supplied as box of 100 (20 packages; 5 plates per package)....
... is a simple high performance method for ... detergents without significant dilution of protein solution. ... the Detergent-OUT Spin column and collect detergent ... for removing detergent from a maximum of ...
... The Chemicon Detergent-OUT Kit is a ... from protein solutions. Removes detergents without ... load the protein solution on the Detergent-OUT ... solution. The Med column is suitable ...
... are derived from frozen embedded tissue blocks, ... procedures to ensure the highest quality. Tissues ... one block, sectioned at a thickness of ... Sections are large (3-5 mm in diameter) ...
Biology Products: